A once-a-day pill to help prevent HIV infection could significantly reduce the spread of AIDS, but only makes economic sense if used in select, high-risk…
Daily HIV antiretroviral pre-exposure prophylaxis (PrEP) is being evaluated in clinical trials among men who have sex with men (MSM). However, daily PrEP may not…
The Global Consultation on MSM and HIV/AIDS Research and this report of proceedings represent only the first steps in a collaborative and ongoing process that…